Current management of diabetes insipidus.
D001581:Benzothiadiazines; D002220:Carbamazepine / Q000627:therapeutic use; D002747:Chlorpropamide / Q000627:therapeutic use; D002994:Clofibrate / Q000627:therapeutic use; D003894:Deamino Arginine Vasopressin / Q000627:therapeutic use; D003919:Diabetes Insipidus / Q000188:drug therapy* / Q000209:etiology; D004232:Diuretics; D006801:Humans; D008236:Lypressin / Q000627:therapeutic use; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use; D014667:Vasopressins / Q000627:therapeutic use
D001581:Benzothiadiazines; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors; D014667:Vasopressins; D002220:Carbamazepine; D008236:Lypressin; D003894:Deamino Arginine Vasopressin; D002994:Clofibrate; D002747:Chlorpropamide